Ara
Toplam kayıt 34, listelenen: 1-10
Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group
(Imprimatur Publications, 2019)
Purpose: Advanced gastric cancer has a dismal prognosis. Platin/5-fluorouracil (PF) combination chemotherapy is the main treatment modality for metastatic gastric cancer patients. Third drug addition to PF is a controversial ...
Efficacy of clarithromycin as a protective agent in the methotrexate-induced pulmonary fibrosis model
(Termedia Publishing House Ltd, 2018)
Introduction: Methotrexate is a cytotoxic agent used in leukemia, and several other cancer types and at lower doses in auto-inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis and psoriasis. Macrolide ...
The Scientific Efforts in the Turkish Oncological History During the First Ten Years of the Turkish Republic
(Galenos Yayincilik, 2018)
A small number of physicians strived to increase scientific knowledge on cancer despite the hardships of the early and difficult years of the Turkish Republic. For instance, Hamdi Suat took his place in the international ...
Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer
(Sage Publications Ltd, 2019)
Objective This study aimed to evaluate the efficacy and safety profile of capecitabine and oxaliplatin (CAPOX) and 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) regimens as adjuvant treatment in patients with stage ...
Evaluation of oxaliplatin-induced pulmonary toxicity in rats
(Termedia Publishing House Ltd, 2019)
Introduction: The mechanism of oxaliplatin (OXA) induced pulmonary toxi-city is not fully understood. Aim of the study: The present study was designed to investigate the pulmonary toxicity of OXA that has been reported in ...
A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solution Proposals
(Akad Doktorlar Yayinevi, 2014)
There is a new improvement in oncology nearly in every day as a result of preclinical or clinical. As the number of publication per capita, Turkey is far behind the other developed European countries. For example, the ...
Multicenter Evaluation of Patients with Cutaneous Malignant Melanoma in Turkey: MELAS Study
(Asian Pacific Organization Cancer Prevention, 2013)
Background: Malignant melanoma is a cancer that demonstrates rapid progression and atypical clinically features with a poor prognosis. Aim: This study was performed to determine the clinical characteristics and treatment ...
Evaluation of Cancer Patients Admitted to the Emergency Department within One Month before Death in Turkey: What are the Problems Needing Attention?
(Asian Pacific Organization Cancer Prevention, 2014)
Background: Although previously studies have reported that most patients with malignancy prefer to die at home, this is not the real situation in clinical practice. Aim: In this study, we aimed to determine the characteristics ...
Single Center Experience on Causes of Cancer Patients Visiting the Emergency Department in Southwest Turkey
(Asian Pacific Organization Cancer Prevention, 2014)
Background: Emergency departments are visited by cancer patients for palliation of cancer-related symptoms, management of treatment-related side effects, oncologic emergencies, co-morbidities, and/or end of life care. In ...
Predictive Value of Baseline Plasma D-dimers for Chemotherapy-induced Thrombocytopenia in Patients with Stage III Colon Cancer: A Pilot Study
(Asian Pacific Organization Cancer Prevention, 2013)
Background: : Chemotherapy-induced thrombocytopenia (CIT) is an important cause of morbitity in patients with cancer. Aim: To investigate the effect of the baseline plasma D-dimer level, an important marker for thrombotic ...